Skip to main content
MultiPlan Corporation (MPLN)
NYSE: MPLN · Real-Time Price · USD
6.94
-0.08 (-1.14%)
Nov 22, 2024, 4:00 PM EST - Market closed

MultiPlan Revenue

MultiPlan had revenue of $230.50M in the quarter ending September 30, 2024, a decrease of -5.07%. This brings the company's revenue in the last twelve months to $942.61M, down -1.66% year-over-year. In the year 2023, MultiPlan had annual revenue of $961.52M, down -10.95%.

Revenue (ttm)
$942.61M
Revenue Growth
-1.66%
P/S Ratio
0.12
Revenue / Employee
$336,648
Employees
2,800
Market Cap
112.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023961.52M-118.19M-10.95%
Dec 31, 20221.08B-37.89M-3.39%
Dec 31, 20211.12B179.84M19.18%
Dec 31, 2020937.76M-45.14M-4.59%
Dec 31, 2019982.90M-57.98M-5.57%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Quipt Home Medical 244.23M
Akoya Biosciences 86.82M
Journey Medical 57.77M
Cidara Therapeutics 44.65M
Century Therapeutics 2.68M
Inovio Pharmaceuticals 203.41K
INmune Bio 42.00K
Revenue Rankings

MPLN News

More News